Abstract: Immune checkpoint inhibitors, PD-1 monoclonal antibodies, have been indicated as helpful in the treatment of Recurrence cervical cancer. Nonetheless, predicting therapeutic outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results